uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 11 2022 - 7:05AM
uniQure N.V. (NASDAQ: QURE), a leading gene therapy company
advancing transformative therapies for patients with severe medical
needs, today announced that the Company granted equity awards to 32
newly hired employees as a material inducement to commencing their
employment. The equity grants were approved on April 29, 2022 (the
“Grant Date”) in accordance with Nasdaq Listing Rule 5635(c)(4).
In the aggregate, the employees received 84,900
restricted stock units (“RSUs”) and options to purchase 119,000
ordinary shares of uniQure. Each option has an exercise price of
$14.94 per share, the closing price per ordinary share as reported
by Nasdaq on the Grant Date. Each option has a ten-year term and
will vest over four years from the Grant Date, with 25% of the
original number of shares vesting on the first anniversary of the
Grant Date and an additional 6.25% of the shares vesting in
approximately equal quarterly installments over the twelve
successive quarters following the first anniversary of the Grant
Date. The RSUs will vest over three years, with one-third of the
RSUs vesting annually on each successive anniversary of the Grant
Date. The vesting of each grant of options and RSUs is subject to
the employee’s continued service with the Company through the
applicable vesting dates.
About uniQure
uniQure is delivering on the promise of gene
therapy – single treatments with potentially curative results. We
are leveraging our modular and validated technology platform to
rapidly advance a pipeline of proprietary gene therapies to treat
patients with hemophilia B, Huntington's disease, refractory
temporal lobe epilepsy, Fabry disease, and other
diseases. www.uniQure.com
uniQure Contacts:
FOR
INVESTORS: |
|
|
|
FOR
MEDIA: |
|
|
|
|
|
Maria E. Cantor |
|
Chiara Russo |
|
Tom Malone |
Direct: 339-970-7536 |
|
Direct: 617-306-9137 |
|
Direct: 339-970-7558 |
Mobile: 617-680-9452 |
|
Mobile: 617-306-9137 |
|
Mobile:339-223-8541 |
m.cantor@uniQure.com |
|
c.russo@uniQure.com |
|
t.malone@uniQure.com |
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024